EVALUATING THE RISKS OF WITHDRAWAL SYMPTOMS AND REBOUND INSOMNIA UPON DISCONTINUATION OF DARIDOREXANT IN PATIENTS WITH INSOMNIA DISORDER

被引：0
|
作者：
Leger, D. [1 ]
Fietze, I. [2 ]
Pain, S. [3 ]
Kinter, D. Seboek [3 ]
Flamion, B. [3 ]
Mignot, E. [4 ]
机构：
[1] Univ Paris 05, AP HP, Paris, France
[2] Univ Hosp, Ctr Sleep Med, Charit, Berlin, Germany
[3] Idorsia Pharmaceut Ltd, Allschwil, Switzerland
[4] Stanford Med, Ctr Narcolepsy, Palo Alto, CA USA
来源：
SLEEP MEDICINE | 2022年 / 100卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Daridorexant in elderly Patients with Insomnia
    Mayer, Geert
    Kinter, Dalma Seboek
    Pain, Scott
    Mayleben, David
    Bassetti, Claudio
    Gimona, Alberto
    INTERNIST, 2022, 63 (SUPPL 3): : 320 - 320
  • [22] Long-term safety and efficacy of daridorexant in Japanese patients with insomnia disorder
    Uchimura, Naohisa
    Ozone, Motohiro
    Suzuki, Masahiro
    Taniguchi, Mitsutaka
    Kuriyama, Kenichi
    Togo, Osamu
    Uchiyama, Makoto
    SLEEP MEDICINE, 2024, 122 : 64 - 70
  • [23] Effect of daridorexant on wakefulness throughout the night and morning sleepiness in patients with insomnia disorder
    Dauvilliers, Yves
    Zammit, Gary
    Luyet, Pierre-Philippe
    Braunstein, Guy
    Olivieri, Antonio
    JOURNAL OF SLEEP RESEARCH, 2024, 33
  • [24] Rebound insomnia after hypnotic withdrawal in insomniac outpatients
    G. Hajak
    P. Clarenbach
    W. Fischer
    A. Rodenbeck
    B. Bandelow
    A. Broocks
    E. Rüther
    European Archives of Psychiatry and Clinical Neuroscience, 1998, 248 : 148 - 156
  • [25] Rebound insomnia after hypnotic withdrawal in insomniac outpatients
    Hajak, G
    Clarenbach, P
    Fischer, W
    Rodenbeck, A
    Bandelow, B
    Broocks, A
    Ruther, E
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1998, 248 (03) : 148 - 156
  • [26] Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
    Tobias Di Marco
    Thomas E. Scammell
    Michael Meinel
    Dalma Seboek Kinter
    Alexandre N. Datta
    Gary Zammit
    Yves Dauvilliers
    CNS Drugs, 2023, 37 : 639 - 653
  • [27] DAYTIME INSOMNIA SYMPTOMS NEGATIVELY PREDICT ANHEDONIA IN PATIENTS WITH COMORBID MAJOR DEPRESSIVE DISORDER AND INSOMNIA DISORDER
    Osorno, R. A.
    Kaplan, K.
    Krystal, A.
    Buysse, D.
    Edinger, J.
    Manber, R.
    SLEEP, 2018, 41 : A361 - A362
  • [28] Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
    Di Marco, Tobias
    Scammell, Thomas E.
    Meinel, Michael
    Seboek Kinter, Dalma
    Datta, Alexandre N.
    Zammit, Gary
    Dauvilliers, Yves
    CNS DRUGS, 2023, 37 (7) : 639 - 653
  • [29] Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder
    Dauvilliers, Yves
    Zammit, Gary
    Fietze, Ingo
    Mayleben, David
    Seboek Kinter, Dalma
    Pain, Scott
    Hedner, Jan
    ANNALS OF NEUROLOGY, 2020, 87 (03) : 347 - 356
  • [30] REBOUND INSOMNIA IN NEUROLEPTIC DRUG-WITHDRAWAL NEUROPHYSIOLOGIC CHARACTERISTICS
    VANSWEDEN, B
    PHARMACOPSYCHIATRY, 1987, 20 (03) : 116 - 119
12345